Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Crinetics Pharmaceuticals

Request full access

Novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers

San Diego, United StatesFounded 2008Biotech & Life Sciences

About Crinetics Pharmaceuticals

Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company specializing in the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company operates in the biopharmaceutical market, targeting conditions that have limited treatment options. Crinetics serves patients with rare endocrine disorders, such as acromegaly, by developing innovative oral treatments like CRN00808, which is currently in Phase 2 clinical trials. The business model focuses on advancing drug candidates through clinical trials and obtaining regulatory approvals to bring these therapies to market. Revenue is generated through the commercialization of approved drugs and potential partnerships or licensing agreements with larger pharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2018

Crinetics Pharmaceuticals in the San Diego ecosystem

Live from Dealroom

The Crinetics Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

20 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • National Institutes of Health
  • National Eye Institute

Series A6 investors entered at this stage

Series B and later12 investors entered at this stage

Team profiled 15 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$79M

46 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Crinetics Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.